Joshua Titus with Gozio

Joshua from Gozeo joins Amy on Panda Perspectives to discuss how Gozeo is personalizing the patient experience through mobile solutions. Gozeo, a healthcare IT company, serves as a digital front door for health systems, helping engage patients, visitors, and staff. Joshua highlights the growing trend of personalization in healthcare, emphasizing how mobile platforms can tailor the journey for individuals based on their specific needs. He shares a concrete example of how Gozeo’s mobile experience supports expectant mothers, providing customized information and resources throughout their pregnancy. Joshua also reflects on the shift from educating clients about personalization to now seeing health systems proactively pursuing initiatives in this area. As the industry evolves, he anticipates significant advancements in patient engagement by the end of the year. The conversation underscores Gozeo’s role as a trusted partner in the healthcare space, driving innovation in patient engagement.

Recent Episodes

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…